{
    "10.1002_adhm.201800296.pdf": {
        "new materials": {
            "Yes/No": "No",
            "sentence": " Hydrodynamic diameter was carried out on a Malvern Zetasizer Nano ZS model ZEN3600."
        },
        "screening algorithms": {
            "Yes/No": "No",
            "sentence": " None"
        },
        "experimental methodology": {
            "Yes/No": "No",
            "sentence": " In addition to providing insights into the molecular mechanisms underlying the therapeutic effects of the hybrid peptide, this study revealed the therapeutic potency of a novel hybrid peptide, and supports the use of rational design in development of new antibacterial agents."
        },
        "ML algorithms": {
            "Yes/No": "No",
            "sentence": " No sentence supporting this claim as it is not mentioned in the text snippet."
        },
        "models": {
            "Yes/No": "Yes",
            "sentence": " This nanoplatform provides a promising strategy to improve the targeting efficiency of nanoparticles and the enhancement of tumor-targeting theranostics."
        },
        "funding": {
            "Yes/No": "No",
            "sentence": " The authors declare no conflict of interest."
        },
        "material datasets": {
            "Yes/No": "No",
            "sentence": ""
        },
        "drug formulations explored": {
            "Yes/No": "No",
            "sentence": " Bioconjugate Chem. 2006, 17, 865; c) G. A. van Tilborg, W. J. Mulder, N. Deckers, G. Storm, C. P. Reutelingsperger, G. J. Strijkers, K. Nicolay, Bioconjugate Chem. 2006, 17, 741;"
        },
        "novel drug formulations": {
            "Yes/No": "Yes",
            "sentence": " MNPs"
        },
        "lead small-molecule drug candidates": {
            "Yes/No": "No",
            "sentence": " None"
        },
        "clinical trials": {
            "Yes/No": "No",
            "sentence": ""
        }
    }
}